Catecholamines induce an inflammatory response in human hepatocytes
- 1 March 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 36 (3), 848-854
- https://doi.org/10.1097/ccm.0b013e31816532be
Abstract
The liver is an early target organ in sepsis, severe sepsis, and septic shock, contributing to multiple organ failure, and both lipopolysaccharide and gut-derived catecholamines are implicated in the occurrence of hepatocellular dysfunction. Treatment of septic shock involves administration of vasoactive agents such as exogenous catecholamines or vasopressin in order to reestablish blood pressure. As a prelude to clinical application, we tested the hypothesis that catecholamines could modulate the lipopolysaccharide-induced inflammatory response and function in human liver. An in vitro human cell culture study. Research laboratory of an academic institution. Primary human hepatocytes and human hepatoma HepaRG cells. Primary human hepatocytes and human hepatoma HepaRG cells were exposed to lipopolysaccharide to evaluate effects of epinephrine and several other compounds (norepinephrine, dobutamine, dopamine, dopexamine, phenylephrine, clonidine, salbutamol, and vasopressin). Markers of inflammation (interleukin-6, C-reactive protein) and drug metabolism (cytochrome P450 [CYP] 3A4, CYP2B6, CYP1A2, CYP2E1, constitutive androstane receptor, pregnane X receptor) were analyzed. Transcripts of C-reactive protein and CYP3A4 were strongly increased and depressed respectively after a 24-hr treatment with 10 ng/mL lipopolysaccharide. Co-treatment with either of the catecholamines failed to reverse lipopolysaccharide effects, whereas when added alone, epinephrine, and to a lesser extent norepinephrine, salbutamol, and dobutamine, mimicked lipopolysaccharide effects. Suppression of CYP3A4 implicated beta-adrenergic receptors and was mediated through overproduction of interleukin-6. By contrast, vasopressin did not elicit an inflammatory response or modify CYP3A4 expression. Some catecholamines can induce an inflammatory response and exacerbate the hepatic dysfunction observed during sepsis, favoring the idea that catecholamines could alter the biotransformation of drugs metabolized by CYP3A4 and that alternative vasoactive agents, such as vasopressin, merit further investigation in septic shock patients.This publication has 54 references indexed in Scilit:
- The Association of Sepsis Syndrome and Organ Dysfunction With Mortality in Emergency Department Patients With Suspected InfectionAnnals of Emergency Medicine, 2006
- Lipopolysaccharide signaling induces serum amyloid A (SAA) synthesis in human hepatocytes in vitroFEBS Letters, 2004
- The Epidemiology of Sepsis in the United States from 1979 through 2000The New England Journal of Medicine, 2003
- Role of Toll-Like Receptors in Changes in Gene Expression and NF-κB Activation in Mouse Hepatocytes Stimulated with LipopolysaccharideInfection and Immunity, 2002
- Hepatic response to sepsis: Interaction between coagulation and inflammatory processesCritical Care Medicine, 2001
- Sustained elevation of norepinephrine depresses hepatocellular functionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Kupffer Cells Are Responsible for Producing Inflammatory Cytokines and Hepatocellular Dysfunction during Early SepsisJournal of Surgical Research, 1999
- Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide‐binding protein via CD14JBIC Journal of Biological Inorganic Chemistry, 1999
- The effect of enteric bacterial toxins on the catecholamine levels of the rabbitPathology, 1997
- Prognosis in Acute Organ-System FailureAnnals of Surgery, 1985